Skip to main content
Expand main menu
Close main menu
AllianceRx Walgreens Pharmacy reduces annual patient prescription costs by $6M
Clinical audit programs prevent waste, improve adherence, reduce spend and provide outcomes data, the company said.
Hikma, Glenmark Specialty launch Ryaltris
Ryaltris is used for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older.
Endo files for Chapter 11 bankruptcy
Endo and certain of its subsidiaries initiated voluntary prearranged Chapter 11 proceedings in New York.
Upsher-Smith, Emphascience ink deal for specialty branded generic product
Emphascience will develop the product exclusively for Upsher-Smith, which will manufacture, market and distribute it under its own label in the United States.
Israel Makov to retire as chairman of Sun Pharma
After having led for 10 years, Makov is retiring as Sun Pharma's chairman and member of the board.
Amber Specialty Pharmacy to dispense Pfizer's oncology portfolio
Amber Specialty Pharmacy will begin dispensing 13 Pfizer oncology products.
Marinus launches Ztalmy
Ztalmy is the only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder in patients 2 years of age and older.
Surescripts Specialty Medications Solutions to transform process for prescriptions, savings
In May 2022, prescribers used Real-Time Prescription Benefit to save patients an average of $534.74 per specialty prescription.
Sun Pharma, Cassiopea expand license, supply agreement for Winlevi
Sun Pharma and Cassiopea will bring Winlevi to patients in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Nobelpharma America debuts Hyftor
Hyftor is used to treat facial angiofibroma associated with tuberous sclerosis complex for patients 6 years and older.
Amber Specialty Pharmacy expands Evusheld services
The Hy-Vee subsidiary will offer Evusheld at its 19 locations throughout the U.S.
AllianceRx Walgreens Pharmacy makes new name official
Walgreens announced full ownership of the company in January, necessitating the name change.
Mallinckrodt expected to emerge from Chapter 11 bankruptcy
Mallinckrodt issued 13,170,932 new ordinary shares to its guaranteed unsecured noteholders.
Amneal debuts 2 generics
The company is offering Lyvispah, a baclofen oral granules specialty product, and bexarotene gel, 1%.